(JQUA) JPMorgan U.S. Quality Factor - Overview
Etf: U.S. Stocks, Large-Cap, Quality Factor
Dividends
| Dividend Yield | 1.24% |
| Yield on Cost 5y | 2.17% |
| Yield CAGR 5y | 5.84% |
| Payout Consistency | 98.2% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 12.9% |
| Relative Tail Risk | 3.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.33 |
| Alpha | -5.93 |
| Character TTM | |
|---|---|
| Beta | 0.841 |
| Beta Downside | 0.817 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.81% |
| CAGR/Max DD | 1.07 |
Description: JQUA JPMorgan U.S. Quality Factor January 09, 2026
The JPMorgan U.S. Quality Factor ETF (ticker JQUA) is a U.S.-based large-blend ETF that commits at least 80 % of its net assets (plus any investment-purpose borrowing) to securities that belong to its underlying index, which screens for “quality” characteristics such as high return on equity, stable earnings growth, and low leverage.
From recent data (as of Q4 2024), JQUA carries an expense ratio of roughly 0.15 %, a weighted-average dividend yield near 2.1 %, and a top-sector exposure to consumer staples and health-care-both historically resilient to economic downturns. The fund’s quality screen tends to favor companies with debt-to-equity ratios below 0.5 and ROE above 15 %, metrics that have outperformed the broader market by an average of 1.2 % annualized over the past five years.
Given the current environment of rising interest rates, investors often look to quality-oriented ETFs like JQUA because lower leverage reduces sensitivity to higher borrowing costs, making the factor a potential defensive tilt.
If you want a deeper, data-driven view of how JQUA’s quality exposure stacks up against peers, a quick look at ValueRay’s factor analytics can be a useful next step.
What is the price of JQUA shares?
Over the past week, the price has changed by -0.39%, over one month by -0.40%, over three months by +2.91% and over the past year by +7.95%.
Is JQUA a buy, sell or hold?
What are the forecasts/targets for the JQUA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 74.2 | 15.6% |
JQUA Fundamental Data Overview February 09, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 7.58b USD (7.58b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 7.58b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 7.58b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.01% (E(7.58b)/V(7.58b) * Re(9.01%) + (debt-free company))
Discount Rate = 9.01% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)